remibrutinib
novartis
['remibrutinib', 'louisse']
sjogren s is tough to study, isn t it? louisse (remibrutinib proof-of-concept sjs) - benefit with:
- essdai (primary, obj dx activity) - auto-ab - all patient outcomes has already exceeded many attempts
even then, still some limitations abst1113 #acr22 
Rheumatologist and clinical pharmacologist, world traveller pretences on the upswing, sometimes podcast host for @austprescriber and others. All opinions my own